Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1950 4
1952 1
1955 1
1959 2
1961 1
1964 1
1965 3
1966 1
1967 1
1970 5
1971 2
1972 9
1973 4
1974 5
1975 1
1976 4
1978 2
1979 6
1980 2
1981 8
1982 5
1984 3
1985 2
1986 2
1987 3
1988 3
1989 4
1990 3
1991 6
1992 4
1993 3
1994 3
1995 10
1996 1
1997 4
1998 2
1999 2
2000 3
2001 2
2002 1
2003 3
2004 10
2005 6
2006 4
2007 4
2008 6
2009 4
2010 2
2011 3
2012 2
2013 1
2014 6
2015 3
2016 3
2017 1
2018 2
2019 1
2020 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
A phase 3 trial of bevacizumab in ovarian cancer.
Perren TJ, Swart AM, Pfisterer J, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Kurzeder C, du Bois A, Sehouli J, Kimmig R, Stähle A, Collinson F, Essapen S, Gourley C, Lortholary A, Selle F, Mirza MR, Leminen A, Plante M, Stark D, Qian W, Parmar MK, Oza AM; ICON7 Investigators. Perren TJ, et al. N Engl J Med. 2011 Dec 29;365(26):2484-96. doi: 10.1056/NEJMoa1103799. N Engl J Med. 2011. PMID: 22204725 Free article. Clinical Trial.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial.
Oza AM, Cook AD, Pfisterer J, Embleton A, Ledermann JA, Pujade-Lauraine E, Kristensen G, Carey MS, Beale P, Cervantes A, Park-Simon TW, Rustin G, Joly F, Mirza MR, Plante M, Quinn M, Poveda A, Jayson GC, Stark D, Swart AM, Farrelly L, Kaplan R, Parmar MK, Perren TJ; ICON7 trial investigators. Oza AM, et al. Lancet Oncol. 2015 Aug;16(8):928-36. doi: 10.1016/S1470-2045(15)00086-8. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115797 Free PMC article. Clinical Trial.
Abstracts der 3. Gemeinsamen Brachytherapiekonferenz SASRO/DEGRO/OEGRO.
Ott OJ, Strnad V, Pötter R, Hammer J, Hildebrandt G, Resch A, Kovács G, Beckmann MW, Sauer R, Niehoff P, Polgar C, Ostertag H, Major T, Eidtmann H, Jonat W, Kimmig B, Roddiger SJ, Kolotas C, Kuner RP, Martin T, Kurek R, Baltas D, Rogge B, Kautschur H, Hoffmann G, Pollow B, Kontova M, Zamboglou N, Ott O, Lotter M, Gallino A, Mahler F, Niewald M, Jafari F, Hennen B, Wisser L, Fleckenstein J, Rübe Ch, Böhm M, Micke O, Wagner W, Schäfer U, Willich N, Greiner RH, Pallas A, Pajic B, Collen T, Meurer N, Töpfer M, Ries G, Leutloff U, Frei S, Warszawski A, Baumann R, Möller T, Niedermeyer J, Karstens JH, Gripp S, Muskalla K, Pulte T, Ohmann C, Röddiger S, Dannenberg T, Tunn UW, Dimopoulos J, Schard G, Kirisits C, Lang S, Goldner G, Wachter S, Wachter-Gerstner N, Helbich T, Weise C, Bendel M, Kocher M, Müller RP, Engelmann U, Aebersold DM, Isaak B, Vetterli D, Kemmerling L, Thalmann G, Behrensmeier F, Mini R, Baier K, Wulf J, Nürnberg N, Egberts J, Galalae R, Maurer U, Maurer G, Lang K, Zumbé J, Block T, Czempiel H, Machtens S, Ponholzer A, Riedl A, Oismüller R, Somay C, Hawliczek R, Maier U, Madersbacher S, Hoinkis C, Winkler C, Lehmann D, Hakenberg O, Herrmann T, Messer PM, Gottfri… See abstract for full author list ➔ Ott OJ, et al. Among authors: ostertag h. Strahlenther Onkol. 2004 Jun;180 Suppl 1:109-28. doi: 10.1007/BF03356736. Strahlenther Onkol. 2004. PMID: 27137924 German. No abstract available.
Neuromuscular choristoma.
Mitchell A, Scheithauer BW, Ostertag H, Sepehrnia A, Sav A. Mitchell A, et al. Among authors: ostertag h. Am J Clin Pathol. 1995 Apr;103(4):460-5. doi: 10.1093/ajcp/103.4.460. Am J Clin Pathol. 1995. PMID: 7726144 Review.
Uncommon primary mediastinal tumours.
Macchiarini P, Ostertag H. Macchiarini P, et al. Among authors: ostertag h. Lancet Oncol. 2004 Feb;5(2):107-18. doi: 10.1016/S1470-2045(04)01385-3. Lancet Oncol. 2004. PMID: 14761815 Review.
Percutaneous bone biopsy, techniques and indications.
Berning W, Freyschmidt J, Ostertag H. Berning W, et al. Among authors: ostertag h. Eur Radiol. 1996;6(6):875-81. doi: 10.1007/BF00240695. Eur Radiol. 1996. PMID: 8972325 Review.
Infiltrative mediastinal hemangioma.
Förster C, Ostertag H, Macchiarini P. Förster C, et al. Among authors: ostertag h. Eur J Cardiothorac Surg. 2002 Mar;21(3):541. doi: 10.1016/s1010-7940(02)00008-8. Eur J Cardiothorac Surg. 2002. PMID: 11888777 No abstract available.
[Neurofibromatosis versus schwannomatosis].
Mautner VF, Schröder S, Pulst SM, Ostertag H, Kluwe L. Mautner VF, et al. Among authors: ostertag h. Fortschr Neurol Psychiatr. 1998 Jun;66(6):271-7. doi: 10.1055/s-2007-995262. Fortschr Neurol Psychiatr. 1998. PMID: 9676422 German.
183 results